SCHEMBL29930977

SCHEMBL29930977

COC(=O)c1cccc(OCc2ccccc2)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 2/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 2/20 0.54
GAA P10253 1/20 0.53
PTGER1 P34995 1/20 0.52
BRD4 O60885 1/20 0.51
MAPT P10636 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
HTT P42858 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
RAB9A P51151 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5940976 1.00 SGMS2 (0.54) SGMS2HPGDLMNAGAAPTGER1
SCHEMBL978857 0.88 HTT (0.64) SGMS2LMNAGAAPTGER1BRD4
SCHEMBL25720776 0.85 MAPT (0.63) SGMS2HPGDLMNAGAAPTGER1
SCHEMBL1305662 0.85 HPGD (0.57) SGMS2HPGDLMNAGAAPTGER1
SCHEMBL1097551 0.85 SGMS2 (0.54) SGMS2HPGDLMNAGAAPTGER1
SCHEMBL23231164 0.85 SGMS2 (0.61) SGMS2LMNAGAAPTGER1BRD4
SCHEMBL19511860 0.85 PTGER1 (0.49) SGMS2GAAPTGER1BRD4MAPT
SCHEMBL7050350 0.84 PTGER1 (0.61) SGMS2GAAPTGER1MAPTL3MBTL1
SCHEMBL34466882 0.84 L3MBTL1 (0.53) SGMS2HPGDLMNAGAAPTGER1
SCHEMBL23611725 0.84 NPC1 (0.60) SGMS2HPGDLMNAPTGER1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085056-A1 POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER Berg LLC (US) 2022-11-09 EP disclosed
CN-115210229-A Polycyclic amides as UBE2K modulators for the treatment of cancer 博格有限责任公司 2022-10-18 CN disclosed